How Is The ProMIS Neurosciences Inc (NASDAQ: PMN) Performance Outlook For The Coming Months?

ProMIS Neurosciences Inc (NASDAQ:PMN) has a beta value of -0.08 and has seen 53.81 million shares traded in the recent trading session. The company, currently valued at $25.80M, closed the recent trade at $0.79 per share which meant it gained $0.4 on the day or 102.20% during that session. The PMN stock price is -188.61% off its 52-week high price of $2.28 and 51.9% above the 52-week low of $0.38. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.11 million shares traded. The 3-month trading volume is 55.40K shares.

ProMIS Neurosciences Inc (NASDAQ:PMN) trade information

Sporting 102.20% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PMN stock price touched $0.79 or saw a rise of 36.8%. Year-to-date, ProMIS Neurosciences Inc shares have moved -64.60%, while the 5-day performance has seen it change 93.20%. Over the past 30 days, the shares of ProMIS Neurosciences Inc (NASDAQ:PMN) have changed 47.55%. Short interest in the company has seen 0.14 million shares shorted with days to cover at 3.01.

Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 80.25% from the levels at last check today.. The projected low price target is $4.0 while the price target rests at a high of $4.0. In that case, then, we find that the latest price level in today’s session is -406.33% off the targeted high while a plunge would see the stock gain -406.33% from the levels at last check today..

ProMIS Neurosciences Inc (PMN) estimates and forecasts

The company’s shares have lost -22.61% over the past 6 months.

PMN Dividends

ProMIS Neurosciences Inc is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

ProMIS Neurosciences Inc (NASDAQ:PMN)’s Major holders

Insiders own 27.61% of the company shares, while shares held by institutions stand at 28.56% with a share float percentage of 39.45%. Investors are also buoyed by the number of investors in a company, with ProMIS Neurosciences Inc having a total of 18.0 institutions that hold shares in the company.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.